Position in CGEN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,992
+$28 QoQ
Shares Held
2,800
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 82 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. CGEN ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
69,358 | $34,452,195 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,662 | $10,389,420 | |
| 3 | TECH |
BIO-TECHNE Corp
|
77,074 | $5,445,277 | |
| 4 | MRNA |
Moderna, Inc.
|
70,829 | $4,960,151 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
89,646 | $4,925,149 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
39,473 | $3,847,827 | |
| 7 | INCY |
Incyte Corp
|
32,777 | $3,715,597 | |
| 8 | ARGX |
Argenx SE
|
3,967 | $3,680,460 |
All Filings in CGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,992 | 2,800 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $5,964 | 2,800 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,284 | 2,800 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $4,116 | 2,800 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $4,984 | 2,800 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,088 | 2,800 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,284 | 2,800 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $5,068 | 2,800 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $4,704 | 2,800 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,224 | 2,800 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $5,544 | 2,800 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $2,604 | 2,800 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,363 | 2,950 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,065 | 2,950 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,124 | 2,950 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,907 | 8,950 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,457 | 2,950 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,016 | 2,800 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $12,040 | 2,800 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,104 | 3,200 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $26,496 | 3,200 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $27,488 | 3,200 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $38,752 | 3,200 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $52,000 | 3,200 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $51,068 | 3,400 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $23,958 | 3,300 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||